Vanflyta Tablet, Film Coated
Product Images NDC 65597-511

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vanflyta (NDC 65597-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Daiichi Sankyo Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vanflyta 01)

Chemical structure of quizartinib dihydrochloride depicted as a molecular diagram showing its heterocyclic rings and functional groups.*

FDA Label Image

Figure 1 (Vanflyta 02)

A survival curve chart showing overall survival percentage over months comparing VANFLYTA with placebo. The x-axis represents months from 0 to 60, and the y-axis shows overall survival percentage from 0% to 100%. The graph includes hazard ratio and p-value statistics and a table of the number of patients at risk for both VANFLYTA and placebo groups at various time points.*

FDA Label Image

Principal Display Panel (17.7 mg Tablet Bottle Carton)

VANFLYTA 17.7 mg (quizartinib) tablets packaging label. The label shows 14 film-coated oral tablets per carton, manufactured by Daiichi Sankyo Inc. It instructs to swallow tablets whole and includes storage information at controlled room temperature. The label also states Rx only and to dispense accompanying Medication Guide to each patient.*

FDA Label Image

Principal Display Panel (26.5 mg Tablet Bottle Carton)

Box packaging label for VANFLYTA (quizartinib) tablets 26.5 mg, oral film-coated tablets. The label indicates a package size of 14 tablets, includes warnings to swallow tablets whole, and advises dispensing the accompanying medication guide. Manufactured by Daiichi Sankyo Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.